Performance, transparency, trust

We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page. 

Investors

Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site. 

Read our latest regulatory news

Observe Medical acquires Biim Ultrasound to strengthen its global medtech platform

· Observe Medical will develop and commercialize proprietary, innovative medtech products to the global market · International distributor and partner network with a Nordic direct sales organization · The agreement is set to accelerate the global commercial roll-out of the combined portfolio, including Sippi® US market launch and the entry of Biim in Europe Oslo,…

Read more

Financial calendar

  • 3 November 2021

    Quarterly Presentation - Q3 2021

  • 17 February 2022

    Quarterly Presentation - Q4 2021

  • 29 April 2022

    Annual Report (publish)

  • 12 May 2022

    Quarterly Presentation - Q1 2022

  • 2 June 2022

    Annual General Meeting

  • 25 August 2022

    Quarterly Presentation - Q2 and First Half Report 2022

  • 3 November 2022

    Quarterly Presentation - Q3 2022

The Share

Share performance

Shareholders

Last updated 31 December 2021

NameNumber of shares% of top 20% of totalCountry
1NAVAMEDIC ASA 4,222,727  25.09%21.54%Norway
2INGERØ REITEN INV. COMPANY AS 3,939,394  23.40%20.09%Norway
3RO, LARS 1,501,051  8.92% 7.66%NORWAY
4UBS SWITZERLAND AG 1,419,244 8.43% 7.24%SWITZERLAND
5ARTAL AS 1,064,457 6.32% 5.43%Norway
6ALPINE CAPITAL AS 709,688 4.22% 3.62%Norway
7Soleglad Invest AS 586,668 3.49% 2.99% NORWAY
8NORDA ASA 511,632 3.04% 2.61%NORWAY
9TRANBERGKOLLEN INVEST AS 500,000  2.97% 2.55%Norway
10LEIKERANE AS 373,439  2.22% 1.90%Norway
11LAPAS AS 348,326 2.07% 1.78%Norway
12GINNY INVEST AS 285,000 1.69% 1.45%NORWAY
13PHILIP HOLDING AS 270,000 1.60% 1.38%NORWAY
14KRAEBER VERWALTUNG GMBH 214,850 1.28% 1.10%GERMANY
15cam as 181,000 1.08% 0.92%NORWAY
16BJØRNTVEDT, VEGARD 171,718 1.02% 0.88%NORWAY
17NORDNET BANK AB 166,072 0.99% 0.85%SWEDEN
18MP PENSJON PK 141,663 0.84% 0.72%NORWAY
19ABC INVEST AS 120,000 0.71% 0.61%NORWAY
20EILERAAS, KARL ANSKAR 105,001 0.62% 0.54%Norway
Total numBer owned by top 2016,831,930100.00%85.85%
Total number of shares19,605,457

Basic share data

Stock Exchange:

Ticker:

First day of listing:

Sector:

Trading Currency:

ISIN:

Number of shares issued:

Nominal value:

Euronext Expand Oslo

OBSRV

4 November 2019

Healthcare

NOK

NO0010865009

19 605 457

NOK 0.26

 

Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.

For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no

IR contact

Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com

Per Arne Nygård, Chief Financial Officer
+47 41 10 43 45 / perarne.nygard@observemedical.com

Sign up for the mailing list